Suchergebnisse - "Zhao, Jinkai"

PubPharm (24)

1

The Impact of Income Inequality on Health Levels : Empirical Evidence from China:2002-2016

enthalten in: Social work in public health | 2024

von Zhao, J. | Yang, W. | Zhao, K.

2

The efficacy and safety of adding anlotinib in gradual progression on third-generation EGFR-TKIs for EGFR-mutant advanced nonsmall cell lung cancer

enthalten in: Anti-cancer drugs | 2024

von Xiang, H. | Danna, D. | Xuefei, C. | +2

3

Depression and hepatobiliary diseases : a bidirectional Mendelian randomization study

enthalten in: Frontiers in psychiatry | 2024

von Kong, Y. | Yao, Z. | Ren, L. | +4

4

The efficacy and safety of adding anlotinib in gradual progression on third-generation EGFR-TKIs for EGFR-mutant advanced non-small cell lung cancer

enthalten in: ResearchSquare.com | 2023

von Xiang, H. | Ding, D. | Chen, X. | +2

5

Application of schisandrin B in treatment of osteosarcoma

enthalten in: Europäisches Patentamt | 2023

von ZHOU LIQIN | LOU DAYONG | MA HUANJIE | +1

6

Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy

enthalten in: Revista Brasileira de farmacognosia | 2023

von Zhou, L. | Zhou, L. | Ma, H. | +2

7

Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy

enthalten in: Revista Brasileira de farmacognosia | 2023

von Zhou, L. | Zhou, L. | Ma, H. | +2

8

Evaluation method of nutritional value of edible blend oil and application of edible blend oil

enthalten in: Europäisches Patentamt | 2022

von WANG LIMING | CHU BAIJUN | ZHAO JINKAI | +5

9

Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells

enthalten in: Journal of gastrointestinal oncology | 2022

von Bian, R. | Zhao, J. | Yao, Z. | +5

10

Application of simvastatin in preparation of medicine for preventing or treating liver cancer

enthalten in: Europäisches Patentamt | 2022

von ZHOU LIQIN | LOU DAYONG | HU FEI | +2